After Arnold called, he came back to report his good news. He saw that Yang Rui had already drunk a bundle of beer with a table of representatives of a pharmaceutical company.

Arnold's eyes, instantly red, as if a man went out to buy an onion, came back to find three used sets in the kitchen, as if a man ran out to buy a set, came back to find six broken balsam pear in the bedroom.

Arnold's heart is like a broken organic bitter gourd - my life, my struggle, my goal, not to do this kind of thing!

"Here comes Arnold. Drink together. " Yang Rui invited Arnold to the table as if nothing had happened, but also called him a nickname.

In the eyes of his colleagues, Arnold sat on the table coldly and said, "Yang Rui, I thought it was true that you promised to give jericham the preemptive right."

"Of course, it's true. Before signing a contract with any enterprise, I will tell jerichon to give you a short quotation time." Yang Rui put down his beer glass and said.

That's what priority is. Arnold had nothing to say. He was disappointed and said, "I thought you would give us a chance to talk about it first, in private."

"If it's emotional, don't do it." Yang Rui knows what Arnold thinks. Today, the cooperation between the two sides has become inseparable. If the British people intercede with each other and use the relationship to speak, Yang Rui can't refuse.

"Jerichon's conditions will satisfy you." Arnold wants to do additional questions too much, especially when his basic questions are not very good.

Yang Rui said: "I know that Jielikang will provide excellent conditions, which will be enough to make up for the efforts of Huarui laboratory. Maybe it will be enough to make up for many times the efforts of Huarui laboratory. But I have to be responsible for Huarui and the researchers including me. We want the best conditions."

Yang Rui looked around and said, "desferridone is my first achievement in the field of pharmacology and the first achievement of Huarui laboratory. I don't know whether it's ability or good luck, or just a flash of inspiration. I have to try my best to fight for what I can fight for. This is my duty, right?"

"I admit that what you said is very reasonable. You want to cash an insurance for Huarui, so that it can operate for many years. I can understand that, but I want to say that Jielikang can be your insurance company. The good relationship with Jielikang can also ensure the long-term operation of Huarui laboratory." Arnold has a lot to say, but he chose this statement because it is a condition that only Jericho can put forward.

No matter how large other companies are, they dare not make such a guarantee without the basis of cooperation with Yang Rui.

Yang Rui picked up the beer cup and sipped it slightly, letting the liquor rotate in his mouth, feeling the bitter taste.

"Yang Rui, Jielikang has world-class resources. What we can provide to you is more likely to be the first in the world. I can guarantee that, even if, I mean, Huarui laboratory has no output in the next seven years, I can guarantee that you are the partners of Jielikang and enjoy the treatment of first-class laboratory." Arnold again offered a condition that no other company could offer.

In fact, he has many conditions, such as price, such as authorization, but he does not want to fall into a price war. The relationship between the two sides is Arnold's biggest chip, and the scale of Jericho is his biggest dependence.

I have to say that Yang Rui is a little excited.

Seven years of partnership and the treatment of first-class laboratory are really not words. Moreover, Yang Rui believes that Arnold can realize his promise.

The development of new drugs, especially original drugs, is extremely difficult, and more and more difficult. In the 1950s and 1960s, pharmaceutical companies were keen on developing antibiotics. Almost all of them turned over the bacteria in the soil. Schools such as Harvard launched a campaign to let people mail the soil near their home. At that time, antibiotics appeared at the rate of several kinds a month. It was not difficult for larger pharmaceutical companies to develop more than ten kinds of new drugs a year, but by the 1970s, With the development of technology and strict drug supervision, single digit new drugs have become the norm. As far as Yang Rui knows, after 2010, the time for large pharmaceutical companies to develop new drugs has been expected to last for 10 years - if a new drug can be developed in 10 years, it will be fast.

In this context, the patience of pharmaceutical companies is actually very good. Let alone a young and experienced scholar like Yang Rui, who is a slightly famous professor from a famous university, who has just set foot in this field, the patience of pharmaceutical companies can last for two or three years, or even three or four years.

Seven years is beyond the patience of the normal company, but with Arnold's support and world-class achievement support, Yang Rui is really qualified to get such a commitment.

However, in his heart, Yang Rui didn't want such a promise.

If Yang ruiruo is an ordinary scholar, he should welcome the inseparable relationship. Large multinational pharmaceutical companies are the best partners in the field of biology and medicine. Of course, they will still bully others and customers, but that does not mean that small pharmaceutical companies will not do so. The only difference is that large pharmaceutical companies are more patient, have more financial support, and have stronger capital and executive ability.It's a pity that Yang Rui is not an ordinary researcher. He has too much in his head. More than one Jericho company can't eat it, and any partner can't eat it.

At the present speed, the development of a new original drug in two months may seem to others to be a coincidence or even a fantasy, but for Yang Rui, this is indeed a work that can be copied.

Yang Rui can do what generic drug companies do after the information of original drugs is released.

The only problem is that the complexity of original drugs far exceeds that of generic drugs.

The market value of Jielikang is nearly 100 billion, and the annual sales volume is over 10 billion. But for new drugs, it's not bad to have three kinds of new drugs every year. Moreover, it may be new drugs composed of different compounds with the same target. Just like Yang Rui's desferridone left seven active substances in the end. If these seven active substances have passed the clinical trials, it means that there are seven new drugs.

This is also the reason why deferoxane is valued by many companies. The sales of deferoxane itself may not be high, but it has a great chance to pass clinical trials and go public, which is enough for companies to focus on.

Yang Rui's future work will only attract more and more attention, but the scale of Jielikang can not be expanded rashly.

In fact, pharmaceutical companies often encounter similar situations. For example, there were many compounds synthesized in those years, or there were many targets found in those years. What should we do? It's easy to do. I'll do it next year.

From the company's point of view, this behavior is called technology reserve.

When Wall Street estimates the value of pharmaceutical companies, it is also very important to reserve drugs. Moreover, not only can synthetic compounds be reserved, but also how many phase III clinical trials, how many phase II clinical trials, and how many drugs passed animal experiments can be used as references for reserve and evaluation.

With Yang Rui's speed, he doesn't want his invention to be reserved by the company. Even if the research after the reserve is more profitable, Yang Rui is not willing to.

He needs a lot of money, but his goal is never to make money.

Yang Rui is destined to seek partners other than Jericho.

If you agree to Arnold's promise, or wait until ferroketone goes on the market, Jielikang won't let Yang Rui out easily.

At that time, Jielikang will certainly strengthen the relationship with Yang Rui, which may produce a lot of short-term benefits, but that is not what Yang Rui wants.

Arnold must not have guessed that it was because of his promise that Yang Rui made up his mind.

"I believe you, but Hua Rui wants to rely on himself more." Yang Rui explicitly refused Arnold, then opened a bottle of beer, filled the glass in front of Arnold, gently touched it with a beer bottle and said, "I'll do my duty."

"Do your duty." Yang Rui raised his glass to the others.

"Do your duty!" They all raised their glasses.

Raymond of greenstone corner company drank a large glass of beer in one gulp. These business elites from developed countries really have a sense of "due diligence". If not, who would like to sit on the streets of foreign countries, eat the offal of cattle, sheep and pigs, and smell the rotten smell of stinky tofu.

"How does it taste?" Yang Rui chewed the stewed meat and pushed it to the middle of the table. He said, "these two are my favorite Beijing snacks. You're welcome."

The elites have a big belly and grind their teeth hard.

For a while, the Japanese took the lead to look up, eyes flashing tears, said: "very delicious, Chinese food profound, too delicious."

Raymond also raised his thumb, eyes glittering, choked: "Chinese food, great."

"Just like it, just like it." Yang Rui put down his chopsticks with a smile.

Other people quickly dropped their chopsticks, and the Italians took a deep breath, then suddenly pinched their nose and glared.

"Stinky Tofu doesn't smell good, but it's delicious." Yang Rui explained with a smile and added: "China, like other countries in the world, has a lot of its own characteristics, and Chinese people also have a lot of their own habits, but there are similar problems all over the world. The biggest trouble is that in today's world, I think, it's probably disease."

Yang Rui pointed to himself and the Americans, and said with a smile, "the cold war should no longer be a hot issue."

"Maybe Reagan cares, I don't care." Raymond said with a smile.

"I don't care. What I care about is whether deferonone can go on the market smoothly and as soon as possible." Seeing that Yang Rui finally got to the point, the others straightened up.

"Do you want to have a small auction?" Asked the Italian."No, what I want now is not competition, but cooperation." Yang Rui shook his head and said: "just as I said, I hope that deferroetone can be listed smoothly and as soon as possible. Therefore, I ask that the company that buys deferroetone should have strong strength and strong drug listing ability."

The representatives of several companies are not looking good.

It's not to say that there is a strong drug listing ability. If there is an evaluation standard, a company that has new drugs listed every year is a company with strong drug listing ability, just like a film company that has new films produced every year.

And there will never be more companies that can do that.

More than half of the companies here are not strong.

"Please take it easy." Yang Rui's smile was very infectious. He raised his cup again and said, "I know that different pharmaceutical companies have different business models. For example, some companies are good at drug development..."

He looked at the English and the Norwegians.

"Some companies are good at marketing." Yang Rui looks at American Raymond.

"Some companies are good at developing new indications for existing drugs." Yang Rui looks at the German and Japanese.

"Some companies are good at..." Yang Rui looked at the rest of the Italian, eager to try, said: "good at some other work..."

"But anyway." Yang ruimeng clapped his hands and said with a smile: "the listing of new drugs is a big project. I respect your business mode, but I will choose the company or company combination with the most listing ability."

Apart from the Italians who are still muddling about what "other" is, other companies understand it.

Raymond asked, "do you want you to come together and buy a patent for deferonone?"

"To unite or not to unite is your freedom. But for companies that are more able to go public, I am willing to cede some of my interests. " Yang Rui stopped for a moment and said, "we can bet."

All of a sudden, the representatives of various companies are interested.

The pharmaceutical industry is one of the industries most closely linked with finance. Investment banks are required to participate in the M & A agreements that cost tens of millions of yuan, insurance industry is required to hedge the new drug development that costs hundreds of millions or even billions of yuan, and commercial banks are required to intervene in the sales revenue that costs billions or even tens of billions.

Gambling agreement is the most common contract in new drug development.

It can even be said that gambling is an inevitable contract in the development of new drugs. In the process of new drug development with such a low probability, scientists bet with laboratories, laboratories bet with biotech companies, biotech companies bet with pharmaceutical companies, and pharmaceutical companies bet with Wall Street, It can help professional companies lock in profits to the greatest extent, just as commodity circulation companies lock in risks by futures trading.

Of course, the reason why people like gambling agreements is often not because they lock in profits. More people just like gambling, just like many commodity circulation companies silently change futures hedging transactions into futures hedging and value-added transactions.

For the pharmaceutical companies which are in a dominant position in the bet agreement, they can choose to sell the bet items with higher risks to Wall Street and leave the bet items with lower risks and higher profits to themselves.

Yang Rui's request is equivalent to ensuring the profits of pharmaceutical companies.

Everyone likes a steady profit.